Biological variability of biochemical markers of bone turnover in healthy women

Endocrine Research

Volumn 28, Issue 3, 2002, Pages 257-264

  Takahashi, Masaaki ^a   Kawana, Kouich ^a   Nagano, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; ESTRADIOL; PARATHYROID HORMONE; PEPTIDE; PYRIDINOLINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BONE TURNOVER; DIET RESTRICTION; ESTRADIOL BLOOD LEVEL; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; URINALYSIS; BLOOD; BONE REMODELING; GENETIC VARIABILITY; PHYSIOLOGY; REFERENCE VALUE; URINE;

ADULT; BIOLOGICAL MARKERS; BONE REMODELING; FASTING; FEMALE; HUMANS; REFERENCE VALUES; VARIATION (GENETICS);

EID: 0036443371     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120015063     Document Type: Article

References (13)

1. Calvo, M.S.; Eyre, D.R.; Gundberg, C.M. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev. 1996, 17, 333-368.
2. Garnero, P.; Delmas, P.D. New developments in biochemical markers for osteoporosis. Calcif. Tissue Int. 1996, 59 (Suppl 1), S2-S9.
3. Christenson, R.H. Biochemical markers of bone metabolism: An overview. Clin. Biochem. 1997, 30, 573-593.
4. Aoshima, H.; Kushida, K.; Takahashi, M.; Ohishi, T.; Hoshino, H.; Suzuki, M.; Inoue, T. Circadian variation of urinary type 1 collagen cross-linked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998, 22, 73-78.
5. Gomez, B., Jr.; Ardakani, S.; Ju, J.; Jenkins, D.; Cerelli, M.J.; Daniloff, G.Y.; Kung, V.T. Monoclonal antibody assay for measuring bone specific alkaline phosphatase activity in serum. Clin. Chem. 1995, 41, 1560-1566.
6. Bonde, M.; Garnero, P.; Fledelius, C.; Qvist, P.; Delmas, P.D.; Christiansen, C. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-Telopeptide of type I collagen. J. Bone Miner. Res. 1997, 12, 1028-1034.
7. Bonde, M.; Qvist, P.; Fledelius, C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin. Chem. 1994, 40, 2022-2025.
8. Hanson, D.A.; Weis, M.A.E.; Bollen, A.M.; Maslan, S.L.; Singer, F.R.; Eyre, D.R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J. Bone Miner. Res. 1992, 7, 1251-1258.
9. Takahashi, M.; Ohishi, T.; Aoshima, H.; Kushida, K.; Inoue, T.; Horiuchi, K. Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline, and pentosidine, in hydrolysate. J. Liq. Chromatogr. 1993, 16, 1355-1370.
10. Plebani, M.; Bernardi, D.; Meneghetti, F.M.; Ujika, F.; Zaninotto, M. Biological variability in assessing the clinical value of biochemical markers of bone turnover. Clin. Chim. Acta 2000, 299, 77-86.
11. Ross, S.M.; Fraser, C.G. Biological variation of cardiac markers: Analytical and clinical considerations. Ann. Clin. Biochem. 1998, 35, 80-84.
12. Hannon, R.; Blumsohn, A.; Naylor, K.; Eastell, R. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability. J. Bone Miner. Res. 1998, 13, 1124-1133.
13. Ju, H.S.J.; Leung, S.; Brown, B.; Stringer, M.A.; Leigh, S.; Scherrer, C.; Shepard, K.; Jenkins, D.; Knudsen, J.; Cannon, R. Comparison of analytical performance and biological variability of three bone resorption assays. Clin. Chem. 1997, 43, 1570-1576.